Fig. 5: Day 100 post-allogeneic stem cell transplantation bone marrow assessment of 110 Mayo Clinic CMML patients stratified by bone marrow morphology and cytogenetics. | Blood Cancer Journal

Fig. 5: Day 100 post-allogeneic stem cell transplantation bone marrow assessment of 110 Mayo Clinic CMML patients stratified by bone marrow morphology and cytogenetics.

From: Allogeneic stem cell transplantation in chronic myelomonocytic leukemia: analysis of post-transplant survival and risk factors in 138 Mayo Clinic patients

Fig. 5

Kaplan–Meier curves illustrate post-transplant survival of CMML patients stratified by bone marrow morphology on day 100 post-ASCT in patients who underwent ASCT (A) in chronic phase CMML and B after experiencing blast transformation. C Post-transplant survival stratified by cytogenetics on day 100 post-ASCT in patients who underwent ASCT in chronic phase CMML. Longer post-transplant overall survival was observed in patients who were in morphologic remission and in patients who had normal cytogenetics at day 100 post-transplant.

Back to article page